Re:Schizophrenia study finds new biomarker, drug candidate i...
by lich_king on Friday March 20, 2026 @11:00AM
(#47455560)
Disproportionately many geeks have very strong opinions about psychiatry, probably because we have a lot of people who consider themselves neurodivergent, as well as plenty of folks who experiment with drugs.
Re:Schizophrenia study finds new biomarker, drug candidate i...
by derektank on Friday March 20, 2026 @11:06AM
(#47455658)
Identifying a biomarker for a psychological condition, particularly one like schizophrenia which is hugely disruptive for individuals affected and has a seemingly random onset around early adulthood, is significant in its own right even if it doesn’t lead to a pharmaceutical intervention. It could help identify new risk factors, potential non-pharmaceutical interventions like life style changes, and maybe even identify people who are at risk of developing schizophrenia and preparing them for its onset before their first hallucination and avoiding a downward spiral.
Re:Schizophrenia study finds new biomarker, drug candidate i...
by tokai on Friday March 20, 2026 @11:58AM
(#47456467)
Absolutely nothing strange about following research, and sharing and discussing has nothing to do with elevating.
What is actually weird is how often users here makes it an issue when research papers on novel drugs are shared here.
Re:Schizophrenia study finds new biomarker, drug candidate i...
by lenerdenator on Friday March 20, 2026 @11:21AM
(#47455897)
Given how debilitating schizophrenia can be, and how compromised the current treatments are - hey, you don't mind making uncontrollable strange expressions on your face forever, do you? - things like this give hope, even if it's just a little bit.
Re:Schizophrenia study finds new biomarker, drug candidate i...
by xbar on Friday March 20, 2026 @04:10PM
(#47459974)
You are right: it is, thankfully, no longer extraordinary on a per-biomarker basis.
As yet another step in mapping the space of biomarkers for diseases, it is noteworthy and worth a thumbs-up somewhere in the universe.
Why is it noteworthy on HN? I think it is because HN likes optimistic stories about scientific progress on lots of dimensions.
There is a very active landscape of people developing/validating 'biomarkers' for neurological and psychiatric disorders and developing drugs specifically for those populations with the biomarker present; this news is far from extraordinary.
The real news is when these reach FDA approval.